Agenda Item 11 — Recommitting to accelerate progress towards malaria elimination

The Medicines Patent Pool welcomes the call to accelerate progress towards malaria elimination.
Reaching the 2030 targets of the Global Technical Strategy requires continued investment in tools that work today, as well as timely and affordable access to next generation anti-malarial medicines.
Public health–oriented voluntary licensing is a proven mechanism to deliver access to new medicines; it shortens the time between innovation and availability, lowers prices , and strengthens supply security.
MPP stands ready to apply our model in the field of malaria as new antimalarials advance through the pipeline. This includes working towards the availability of adapted child-friendly formulations of key malaria medicines, in line with the outcomes of the PADO process for malaria convened by the WHO’s Global Accelerator for Paediatric Formulations.